SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-009052
Filing Date
2022-03-03
Accepted
2022-03-03 16:05:54
Documents
1
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4044
  Complete submission text file 0000899243-22-009052.txt   5580
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-254-4445
Vigil Neuroscience, Inc. (Issuer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address
Papapetropoulos Spyridon (Reporting) CIK: 0001832694 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41200 | Film No.: 22708644